With the aim of becoming a leading biobank reference centre, the Limoges University Hospital (France) is equipped with a state-of-the art technical platform. To computerise its centre for biological resources, the University Hospital has chosen the TD-Biobank software.
TD-Biobank has been developed to meet the specific needs of biological resource centres that want to value and promote their biological resources and collections for research, diagnosis and donation. The software offers full traceability and optimal storage management of samples for multisite contexts.
Following a call for tender, TD-Biobank was selected to computerise the CRBioLim, a centre responsible for biological resource collection, storage and specimen management for six laboratories belonging to the Limoges University Hospital. The specialities of these laboratories include Anatomic pathology, Bacteriology, Hematology, Pharmacology, a Mother and Child centre as well as a Centre for Clinical Investigations.
“We opted for TD-Biobank on the grounds that it allows for centralised management while offering a high degree of flexibility. The flexibility of configuration enables the software to be adapted to the specific multisite and multidisciplinary organisational needs. The bioclinical annotation forms are fully customisable, and this furthermore adds value to our biological resources”, explains Edouard Bosvert, Quality and Operations Manager of the CRBioLim.
Another important criterion is the interoperability of the software, which allows for easy integration into existing care systems. “Today, TD-Biobank is interfaced with the main laboratory management system of the university hospital. This interface eliminates multiple data entry, which not only saves us a significant amount of time, but largely reduces the potential for keying errors and provides a greater level of traceability”.
Certification of the CRBioLim was conditional upon the implementation of a biobanking software solution and was obtained in July 2014. “We are optimistic about the follow-up audit, which is to take place in June 2015. TD-Biobank meets the requirements of the standard in terms of traceability and quality. The software is key in the certification process. With the continual support of Technidata, our first four sites have successfully been operating in routine mode since February 2015. We are now considering expanding the CRBioLim to include new laboratories as early as 2016. Our aim is to offer our expertise and to use our cuttingedge technical platform to better respond to the needs of clinical research as well as the pharmaceutical industry – mainly for new in vitro diagnostic testing - both in France and on an international scale,” concludes Bosvert.